Structure-based virtual screening approach to the discovery of p38 MAP kinase inhibitors

被引：10

作者：

Choi, Hwanho ^{[1
]}

Park, Ho Jeong ^{[2
]}

Shin, Jong Chul ^{[2
]}

Ko, Hyun Sun ^{[2
]}

Lee, Jung Kyun ^{[3
]}

Lee, Soyoung ^{[4
]}

Park, Hwangseo ^{[1
]}

Hong, Sungwoo ^{[4
]}

机构：

[1] Sejong Univ, Dept Biosci & Biotechnol, Seoul 143747, South Korea

[2] Catholic Univ, Coll Med, Seoul St Marys Hosp, Dept Obstet & Gynecol, Seoul 137040, South Korea

[3] Soomshinun Oriental Med Clin, Yongin 448170, Gyeonggi Do, South Korea

[4] Korea Adv Inst Sci & Technol, Dept Chem, Taejon 305701, South Korea

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2012年 / 22卷 / 06期

基金：

新加坡国家研究基金会;

关键词：

Virtual screening; Docking; p38; MAPK; Inhibitor; Anti-inflammatory agents; GENETIC ALGORITHM; PROTEIN-KINASE; POTENT; SOLVATION; DOCKING; IDENTIFICATION; DESIGN;

D O I：

10.1016/j.bmcl.2012.01.104

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

p38 Mitogen-activated protein kinase (MAPK) has been considered to be a promising target for the development of therapeutics for various immunologic diseases. Herein we report an example for a successful application of the virtual screening with protein-ligand docking to identify the novel inhibitors of p38 alpha MAPK. These inhibitors were screened for having desirable physicochemical properties as a drug candidate and compound 1-3 revealed a moderate inhibitory activity with IC50 values ranging from 0.7 to 20 mu M. Therefore, they deserve a consideration for further development by structure-activity relationship (SAR) studies to optimize the inhibitory activities. Structural features relevant to the stabilization of the newly identified inhibitors in the ATP-binding site of p38 MAPK are addressed in detail. (C) 2012 Elsevier Ltd. All rights reserved.

引用

下载

页码：2195 / 2199

页数：5

共 50 条

[41] Discovery of a clinical prodrug of a p38α MAP kinase inhibitor
Liu, Chunjian
Lin, James
Hynes, John, Jr.
Wu, Hong
Wrobleski, Stephen
Lin, Shuqun
Dhar, Murali
Vrudhula, Vivekananda M.
Sun, Hung-Hui
Chao, Sam
Zhao, Rulin
Wang, Bei
Chen, Bang-Chi
Everlof, Gerry
Gesenberg, Christoph
Zhang, Hongjian
Marathe, Punit H.
McIntyre, Kim
Gillooly, Kathleen
Shuster, David
Mckinnon, Murray
Dodd, John H.
Barrish, Joel C.
Schieven, Gary L.
Leftheris, Katerina
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 248
[42] Perspective on the Discovery and Scientific Impact of p38 MAP Kinase
Young, Peter R.
JOURNAL OF BIOMOLECULAR SCREENING, 2013, 18 (10) : 1156 - 1163
[43] Discovery of Novel Fibroblast Growth Factor Receptor 1 Kinase Inhibitors by Structure-Based Virtual Screening
Ravindranathan, Krishna P.
Mandiyan, Valsan
Ekkati, Anil R.
Bae, Jae H.
Schlessinger, Joseph
Jorgensen, William L.
JOURNAL OF MEDICINAL CHEMISTRY, 2010, 53 (04) : 1662 - 1672
[44] Discovery of Akt Kinase Inhibitors through Structure-Based Virtual Screening and Their Evaluation as Potential Anticancer Agents
Chuang, Chih-Hung
Cheng, Ta-Chun
Leu, Yu-Ling
Chuang, Kuo-Hsiang
Tzou, Shey-Cherng
Chen, Chien-Shu
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2015, 16 (02) : 3202 - 3212
[45] Identification of novel BRAF kinase inhibitors with structure-based virtual screening
Park, Hwangseo
Choi, Hwanho
Hong, Seunghee
Hong, Sungwoo
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (19) : 5753 - 5756
[46] The discovery and initial optimisation of pyrrole-2-carboxamides as inhibitors of p38α MAP kinase
Down, Kenneth
Bamborough, Paul
Alder, Catherine
Campbell, Amanda
Christopher, John A.
Gerelle, Maria
Ludbrook, Steve
Mallett, Dave
Mellor, Geoff
Miller, David D.
Pearson, Rosannah
Ray, Keith
Solanke, Yemisi
Somers, Don
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (13) : 3936 - 3940
[47] Synthesis and SAR of p38α MAP kinase inhibitors based on heterobicyclic scaffolds
Dhar, T. G. Murali
Wrobleski, Stephen T.
Lin, Shuqun
Furch, Joseph A.
Nirschl, David S.
Fan, Yi
Todderud, Gordon
Pitt, Sidney
Doweyko, Arthur M.
Sack, John S.
Mathur, Arvind
McKinnon, Murray
Barrish, Joel C.
Dodd, John H.
Schieven, Gary L.
Leftheris, Katerina
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (18) : 5019 - 5024
[48] p38 MAP kinase inhibitors: Progress, pitfalls and possibilities
Adams, JL
Gallagher, TF
Boehm, JC
Kassis, S
Gorycki, PD
Gum, RJ
Webb, EF
Sorenson, ME
Smietana, JM
Garigipati, RS
Hall, RF
Ayrton, A
Badger, A
Griswold, DE
Young, PR
Lee, JC
MEDICINAL CHEMISTRY INTO THE MILLENNIUM, 2001, (264): : 163 - 173
[49] Synthesis and Evaluation of Pyridinyltriazoles as Inhibitors of p38 MAP Kinase
Moallem, Seyed Adel
Hadizadeh, Farzin
Abadi, Fatemeh Abdol
Shahraki, Mahmoud
Shamsara, Jamal
IRANIAN JOURNAL OF BASIC MEDICAL SCIENCES, 2012, 15 (04) : 945 - 950
[50] Practical synthesis of heterocyclic p38 MAP kinase inhibitors
Thiel, Oliver R.
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 244

← 1 2 3 4 5 →